Metabolite-mediated Signaling in Cell-to-Cell Spread of Human Cytomegalovirus
人巨细胞病毒细胞间传播中代谢介导的信号转导
基本信息
- 批准号:10304351
- 负责人:
- 金额:$ 37.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-10 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAntiviral AgentsAntiviral ResponseAreaAryl Hydrocarbon ReceptorAttentionAttenuatedBindingBiological AssayBiological ProcessBiologyCRISPR/Cas technologyCause of DeathCellsClinicalCytomegalovirusCytomegalovirus InfectionsDataDiseaseEngineeringEnzymesEquilibriumGoalsHealthHumanHypoxia Inducible FactorImmune responseImmune systemInfectionKnowledgeKynurenineLeadLifeMediatingMediator of activation proteinMetabolicMetabolismModelingMolecularOrganPathogenesisPathway interactionsPregnancyProcessProductionProteinsProvirusesResearchRoleSignal PathwaySignal TransductionSolidStem cell transplantTransplant RecipientsTryptophan Metabolism PathwayVaccinesViralViral ProteinsVirusVirus DiseasesVirus ReplicationWorkattenuationbasechronic infectioncongenital infectiondisabilityextracellularhuman pathogenmetabolomicsnovelnovel strategiesnovel therapeutic interventionpreventreceptor internalizationresponsevirus host interaction
项目摘要
Human cytomegalovirus (HCMV) establishes a life-long persistent infection by evading the immune system, in part, by direct cell-to-cell viral spread. In solid organ or stem cell transplant recipients, HCMV spread leads to end-organ diseases that can cause death. During pregnancy, HCMV spread causes congenital infection and is a leading cause of congenital disabilities. No HCMV treatment offers a cure, and there is no vaccine. Thus, there is a need for new treatments to limit infection based on novel discoveries in HCMV biology. Viral proteins required for HCMV cell-to-cell spread are known, but the host processes involved in HCMV cell-to-cell spread have received less attention. Clinical strains of HCMV spread most efficiently through cell-to-cell means, but the molecular mechanisms—including host metabolic ones—essential to HCMV cell-to-cell spread are largely unknown. Understanding host mechanisms regulating cell-to-cell spread may lead to new understandings of how to reduce HCMV infection. Our research has uncovered a novel role of metabolite signaling in promoting HCMV spread. This project's overall goal is to mechanistically understand virus-host interactions regulating metabolite signaling essential to HCMV cell-to-cell spread. We found a metabolite in tryptophan metabolism—kynurenine (KYN)—enhances HCMV spread. In addition to its metabolic role, KYN is a signaling messenger. KYN signals through aryl hydrocarbon receptor (AhR). We show that activation of AhR supports HCMV replication. Moreover, we found that hypoxia-inducible factor 1α (HIF1α), through its metabolic regulatory function, limits the production of KYN and suppresses HCMV infection. We hypothesize that metabolite-mediated signaling from infected cells to uninfected cells promotes HCMV cell-to-cell spread, which is attenuated by a HIF1α-dependent cellular response. The proposed research will determine molecular mechanisms involved in the enhancement of HCMV infection by KYN-metabolite signaling (aim 1) and define virus-host interactions regulating HIF1α attenuation of HCMV cell-to-cell spread (aim 2). The experimental approach will integrate virus assays, CRISPR/Cas9 engineering, and untargeted metabolomics to understand HCMV biology. Our findings will provide a mechanistic understanding of metabolite signaling and AhR activity in promoting HCMV cell-to-cell spread and the HIF1α-dependent host-response that targets metabolite signaling to reduce infection. Our studies will advance our knowledge in an understudied area of HCMV research that will provide significant steps-forward in developing novel strategies to treat HCMV infection and limit HCMV-related disease.
人巨细胞病毒(HCMV)通过逃避免疫系统,部分通过直接细胞间病毒传播,建立终身持续感染。在实体器官或干细胞移植受者中,HCMV传播导致可导致死亡的终末器官疾病。在怀孕期间,HCMV传播导致先天性感染,是先天性残疾的主要原因。没有HCMV治疗提供治愈,也没有疫苗。因此,需要基于HCMV生物学的新发现的新治疗来限制感染。HCMV细胞间传播所需的病毒蛋白是已知的,但涉及HCMV细胞间传播的宿主过程受到的关注较少。HCMV临床株通过细胞间传播最有效,但HCMV细胞间传播所必需的分子机制(包括宿主代谢机制)在很大程度上尚不清楚。了解宿主调节细胞间传播的机制可能会对如何减少HCMV感染产生新的认识。我们的研究揭示了代谢物信号在促进HCMV传播中的新作用。该项目的总体目标是从机制上了解病毒-宿主相互作用,调节HCMV细胞间传播所必需的代谢物信号。我们发现色氨酸代谢中的代谢产物-犬尿氨酸(KYN)-增强HCMV传播。除了代谢作用外,KYN还是一种信号信使。KYN通过芳香烃受体(AhR)发出信号。我们发现AhR的激活支持HCMV复制。此外,我们发现低氧诱导因子1α(HIF 1 α)通过其代谢调节功能限制KYN的产生并抑制HCMV感染。我们假设,从感染细胞到未感染细胞的代谢物介导的信号传导促进HCMV细胞间传播,而这种传播被HIF 1 α依赖性细胞应答减弱。拟议的研究将确定通过KYN代谢物信号传导增强HCMV感染的分子机制(目的1),并确定调节HCMV细胞间传播的HIF 1 α衰减的病毒-宿主相互作用(目的2)。该实验方法将整合病毒检测,CRISPR/Cas9工程和非靶向代谢组学,以了解HCMV生物学。我们的研究结果将提供代谢物信号传导和AhR活性在促进HCMV细胞间传播和HIF 1 α依赖性宿主反应中的机制性理解,该宿主反应靶向代谢物信号传导以减少感染。我们的研究将推进我们在HCMV研究的未充分研究领域的知识,这将为开发治疗HCMV感染和限制HCMV相关疾病的新策略提供重要的进展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John Gerard Purdy其他文献
John Gerard Purdy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John Gerard Purdy', 18)}}的其他基金
Mechanisms of Human Cytomegalovirus Reprogramming of Lipid Metabolism
人类巨细胞病毒重编程脂质代谢的机制
- 批准号:
10656249 - 财政年份:2021
- 资助金额:
$ 37.1万 - 项目类别:
Metabolite-mediated Signaling in Cell-to-Cell Spread of Human Cytomegalovirus
人巨细胞病毒细胞间传播中代谢介导的信号转导
- 批准号:
10612070 - 财政年份:2021
- 资助金额:
$ 37.1万 - 项目类别:
Metabolite-mediated Signaling in Cell-to-Cell Spread of Human Cytomegalovirus
人巨细胞病毒细胞间传播中代谢介导的信号转导
- 批准号:
10403581 - 财政年份:2021
- 资助金额:
$ 37.1万 - 项目类别:
Mechanisms of Human Cytomegalovirus Reprogramming of Lipid Metabolism
人类巨细胞病毒重编程脂质代谢的机制
- 批准号:
10438866 - 财政年份:2021
- 资助金额:
$ 37.1万 - 项目类别:
Mechanisms of Human Cytomegalovirus Reprogramming of Lipid Metabolism
人类巨细胞病毒重编程脂质代谢的机制
- 批准号:
10273931 - 财政年份:2021
- 资助金额:
$ 37.1万 - 项目类别:
相似海外基金
Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
- 批准号:
23K18186 - 财政年份:2023
- 资助金额:
$ 37.1万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
$ 37.1万 - 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10730692 - 财政年份:2021
- 资助金额:
$ 37.1万 - 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
- 批准号:
21K06459 - 财政年份:2021
- 资助金额:
$ 37.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10189880 - 财政年份:2021
- 资助金额:
$ 37.1万 - 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
- 批准号:
2404261 - 财政年份:2020
- 资助金额:
$ 37.1万 - 项目类别:
Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10222540 - 财政年份:2020
- 资助金额:
$ 37.1万 - 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 37.1万 - 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
- 批准号:
20K10713 - 财政年份:2020
- 资助金额:
$ 37.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10174522 - 财政年份:2020
- 资助金额:
$ 37.1万 - 项目类别: